Abstract：Objective To observe the clinical efficacy and safety of Shaoyaogoutengmuer Tang in the treatment of primary trigeminal neuralgia. Methods Eighty patients with primary trigeminal neuralgia who were treated in the hospital between March 2016 and March 2017 were selected. Forty of these cases were treated with carbamazepine (control group), and the rest were treated with Shaoyaogoutengmuer Tang (observation group). The therapeutic effects and adverse reactions were compared between the two groups. Results The effective rate of the Shaoyaogoutengmuer Tang group was 82.5%, compared with 72.5% in the control group.Eleven cases were regarded as invalid.There was no significant difference in VAS scores or LSI-B scores between the two groups before treatment. After treatment of 4 weeks, the VAS score of the Shaoyaogoutengmuer Tang group (2.9±0.9) was lower than that of the carbamazepine group (3.2±0.8), while the LSI-B score of the Shaoyaogoutengmuer Tang group (16.0±2.6) was higher than that of the carbamazepine group (13.6±3.3). Conclusions Shaoyaogoutengmuer Tang has a lower VAS score but a higher LSI-B score than carbamazepine in the treatment of primary trigeminal neuralgia. Shaoyaogoutengmuer Tang causes fewer adverse reactions and is superior to carbamazepine, which is a safe and effective treatment.
杨超, 王梦, 马明. 芍药钩藤木耳汤治疗原发性三叉神经痛的疗效及安全性[J]. 武警医学, 2019, 30(4): 341-344.
YANG Chao, WANG Meng, MA Ming. Efficacy of Shaoyaogoutengmuer Tang in the treatment of primary trigeminal neuralgia. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(4): 341-344.
Ömer Fatih Sahin, Kiliç E T, Aksoy Y,et al. The importance of perfusion index monitoring in evaluating the efficacy of stellate ganglion blockage treatment in Raynaud’s disease[J]. Libyan J Med, 2018, 13(1): 1422666.
[2]
Mukherjee A A, Kandhare A D, Bodhankar S L. Evaluation of health-related quality of life in hemolytic uraemic syndrome patients treated with eculizumab: a systematic evaluation on basis of EMPRO[J]. Ren Fail, 2018, 40(1): 107.
Maarbjerg S, Di S G, Bendtsen L, et al. Trigeminal neuralgia - diagnosis and treatment[J]. Cephalalgia, 2017, 37(7): 648-657.
[6]
Di S G, La C S, Truini A, et al. Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain[J]. Clin Neurophysiol, 2014, 15(1): 34.
Yu H Y, Liu M G, Liu D N, et al. Antinociceptive effects of systemic paeoniflorin on bee venom-induced various 'phenotypes' of nociception and hypersensitivity[J]. Pharmacol Biochem Behav, 2007, 88(2): 131-140.
2019, Vol. 30 
